Physician profile
Scott A Nemec
NPI 1215151568
$12,689.30
in general payments reported to CMS, 2019-2025
12 companies · $253 in 2025
The $253 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.84 · 2020: $86.21 · 2022: $42.96 · 2023: $12K · 2024: $256 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $5,408 · Travel and Lodging: $3,981 · Grant: $2,500 · Food and Beverage: $657.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $5,408.27 |
| Travel and Lodging | $3,980.88 |
| Grant | $2,500.00 |
| Food and Beverage | $657.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $11,710.00 | 2023 | Colink Plating System, Fracture and Correction Colag 2 |
| Carbofix Orthopedics INC | $408.27 | 2023-2025 | |
| Depuy Synthes Sales INC. | $173.75 | 2024-2025 | Na |
| Stryker Corporation | $172.90 | 2022-2025 | Actishield, Invision, Prostep Mica |
| Ossio INC | $58.12 | 2020 | |
| Bioventus LLC | $28.28 | 2019-2023 | Exogen Ultrasound Bone Healing System |
| Conmed Corporation | $28.09 | 2020 | |
| In2bones USA, LLC | $26.43 | 2022 | |
| Ebi, LLC | $23.66 | 2025 | Biomet Ebi Bone Healing System, Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Medwest Associates | $21.39 | 2023 | |
| Baxter Healthcare | $20.37 | 2023 | Floseal |
| Orthofix Medical, INC. | $18.04 | 2023 | Spinal-Stim, Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Nemec listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.